Literature DB >> 31956929

Malignancy predicts outcome of Takotsubo syndrome: a systematic review and meta-analysis.

Shaohua Guo1, Bingxin Xie1, Gary Tse1,2, Leonardo Roever3, Yunlong Xia4, Guangping Li1, Yaogang Wang5, Tong Liu6.   

Abstract

Over the recent years, studies have emerged reporting on a strong relationship between the occurrence of malignancy and Takotsubo syndrome. The aim of this systematic review and meta-analysis is to evaluate the predictive value of malignancy for prognosis of Takotsubo syndrome patients. PubMed, EMBASE, Cochrane Library, Web of science, and Scopus were searched until 4 September 2019 for articles concerning association of malignancy with the prognosis of Takotsubo syndrome. A total of ten studies were finally included in this meta-analysis, demonstrating that malignancy was associated with higher mortality in Takotsubo syndrome patients (RR 2.23, 95% CI 1.64-3.03, Z = 5.10, P < 0.00001). Differences between individual studies were significant, which were due to sample size and percentage of malignant patients in each study indicated by meta-regression and then verified by sensitivity analysis. Subgroup analysis demonstrated that the predictive value of malignancy in mortality risk of Takotsubo syndrome patients was significant for both in-hospital death (RR 2.26, 95% CI 1.34-3.82, Z = 3.06, P = 0.002) and follow-up death (RR 2.04, 95% CI 1.63-2.55, Z = 6.21, P < 0.00001). Further analysis of other in-hospital outcomes demonstrated increased incidence of mechanical ventilation in cancer patients. Our meta-analysis suggested that malignancy plays a significant role in predicting the mortality of Takotsubo syndrome patients whether in the short term or long term.

Entities:  

Keywords:  Cancer; Malignancy; Mortality; Prognosis; Stress cardiomyopathy; Takotsubo syndrome

Mesh:

Year:  2020        PMID: 31956929     DOI: 10.1007/s10741-020-09917-z

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  34 in total

1.  5-Fluorouracil-induced Tako-Tsubo-like syndrome.

Authors:  Cécile Basselin; Thierry Fontanges; Jacques Descotes; Philippe Chevalier; Bernard Bui-Xuan; Gwennaelle Feinard; Quadiri Timour
Journal:  Pharmacotherapy       Date:  2011-02       Impact factor: 4.705

2.  Impact of Malignancies in the Early and Late Time Course of Takotsubo Cardiomyopathy.

Authors:  Mélanie Girardey; Laurence Jesel; Umberto Campia; Nathan Messas; Sébastien Hess; Alessio Imperiale; Cyrille Blondet; Annie Trinh; Patrick Ohlmann; Olivier Morel
Journal:  Circ J       Date:  2016-09-01       Impact factor: 2.993

3.  Prevalence and long-term prognostic impact of malignancy in patients with Takotsubo syndrome.

Authors:  Christian Möller; Thomas Stiermaier; Tobias Graf; Charlotte Eitel; Holger Thiele; Christof Burgdorf; Ingo Eitel
Journal:  Eur J Heart Fail       Date:  2017-08-28       Impact factor: 15.534

Review 4.  Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology.

Authors:  R Todd Hurst; Abhiram Prasad; J Wells Askew; Partho P Sengupta; A Jamil Tajik
Journal:  JACC Cardiovasc Imaging       Date:  2010-06

5.  Out-of-hospital versus in-hospital Takotsubo cardiomyopathy: analysis of 3719 patients in the Diagnosis Procedure Combination database in Japan.

Authors:  Toshiaki Isogai; Hideo Yasunaga; Hiroki Matsui; Hiroyuki Tanaka; Tetsuro Ueda; Hiromasa Horiguchi; Kiyohide Fushimi
Journal:  Int J Cardiol       Date:  2014-08-01       Impact factor: 4.164

6.  Clinical Outcome of Takotsubo Cardiomyopathy Diagnosed With or Without Coronary Angiography.

Authors:  Naoki Misumida; Gbolahan O Ogunbayo; Sun Moon Kim; Ahmed Abdel-Latif; Khaled M Ziada; Vincent L Sorrell
Journal:  Angiology       Date:  2018-06-18       Impact factor: 3.619

Review 7.  Capecitabine-Induced Takotsubo Cardiomyopathy: A Case Report and Literature Review.

Authors:  Abdulraheem Qasem; Aref A Bin Abdulhak; Abdelrahman Aly; Jill Moormeier
Journal:  Am J Ther       Date:  2016 Sep-Oct       Impact factor: 2.688

8.  Long-term prognosis of the transient left ventricular dysfunction syndrome (Tako-Tsubo cardiomyopathy): focus on malignancies.

Authors:  Christof Burgdorf; Volkhard Kurowski; Hendrik Bonnemeier; Heribert Schunkert; Peter Walter Radke
Journal:  Eur J Heart Fail       Date:  2008-08-08       Impact factor: 15.534

9.  Outcomes of Takotsubo cardiomyopathy in hospitalized cancer patients.

Authors:  Parijat Saurav Joy; Achuta Kumar Guddati; Iuliana Shapira
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-14       Impact factor: 4.553

10.  Long term outcome of patients suffering from cancer and Takotsubo syndrome or myocardial infarction.

Authors:  K Sattler; I El-Battrawy; T Gietzen; S Lang; X Zhou; M Borggrefe; I Akin
Journal:  QJM       Date:  2018-07-01
View more
  2 in total

1.  A Case of Takotsubo Cardiomyopathy Diagnosed After Postponement of Surgery Due to Hypotension and Electrocardiogram Abnormality Upon Entering the Operating Room.

Authors:  Kana Kikuchi; Takao Kato; Kaoru Koyama
Journal:  Cureus       Date:  2022-05-27

Review 2.  Takotsubo Syndrome: Translational Implications and Pathomechanisms.

Authors:  Xuehui Fan; Guoqiang Yang; Jacqueline Kowitz; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.